Ke Liang
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 10%
- Topics
- PI3K/AKT/mTOR signaling in cancer (10 papers)HER2/EGFR in Cancer Research (8 papers)Ubiquitin and proteasome pathways (6 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Ke Liang
73 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 2.0k
- Oncology 1.2k
- Cancer Research 925
- Pulmonary and Respiratory Medicine 454
- Immunology 272
Countries citing papers authored by Ke Liang
This map shows the geographic impact of Ke Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Liang more than expected).
Fields of papers citing papers by Ke Liang
This network shows the impact of papers produced by Ke Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Liang. The network helps show where Ke Liang may publish in the future.
Co-authorship network of co-authors of Ke Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Ke Liang. A scholar is included among the top collaborators of Ke Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Liang. Ke Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 28 | |
| 5 | 6 | |
| 6 | 55 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 25 | |
| 10 | 39 | |
| 11 | 246 | |
| 12 | 5 | |
| 13 | 6 | |
| 14 | Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance to the anti-EGFR monoclonal antibody cetuximab | 3 |
| 15 | Screening of EGFR-regulated Secreted Proteins in Human NPC Cell Line CNE2 | 3 |
| 16 | 18 | |
| 17 | 258 | |
| 18 | 88 | |
| 19 | Sensitization of breast cancer cells to radiation by trastuzumab. | 201 |
| 20 | 1 |
About Ke Liang
Ke Liang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 79 papers that have together received 3.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (10 papers), HER2/EGFR in Cancer Research (8 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Cancer Research (925 citations), Oncology (1.2k citations) and Molecular Biology (2.0k citations). Ke Liang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Zhen Fan, Yang Lü, Weidong Jin, Luka Milas, Gordon B. Mills, K. Kian Ang, Bolin Liu, Xinqun Li, John Mendelsohn and Chunru Lin. Their work appears in journals such as Cell, Nucleic Acids Research and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.